Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients

Anesthesiology

Volumn 110, Issue 2, 2009, Pages 284-294

  Plaud, Benôt ^a,i   Meretoja, Olli ^b   Hofmockel, Rainer ^c   Raft, Julien ^d   Stoddart, Peter A ^e   Van Kuijk, Jacqueline H M ^f   Hermens, Yvonne ^g   Mirakhur, Rajinder K ^h  

^a UNIVERSITÉ DE CAEN   (France)

^b UNIVERSITY OF HELSINKI   (Finland)

^c Klinik und Poliklinik för Anästhesiologie und Intensivtherapie   (Germany)

^d CHU NANCY BRABOIS   (France)

^e BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

^f Statistician   (France)

^g Clinical Research Scientist   (France)

^h QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

ⁱ UNIVERSITÉ PARIS EST CRÉTEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLONIDINE; OPIATE; PLACEBO; PROPOFOL; ROCURONIUM; SUGAMMADEX; ANDROSTANE DERIVATIVE; GAMMA CYCLODEXTRIN DERIVATIVE; NEUROMUSCULAR BLOCKING AGENT;

ABNORMAL LABORATORY RESULT; ADOLESCENT; ADULT; AGE; AGED; ANEMIA; ANESTHETIC RECOVERY; ANOREXIA; ARTICLE; CHILD; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG FEVER; DRUG SAFETY; DYSURIA; FEMALE; HEMATURIA; HOT FLUSH; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MUSCLE SPASM; NEUROMUSCULAR BLOCKING; OLIGURIA; PAIN; PARESTHESIA; PATIENT MONITORING; PHARYNGITIS; PHASE 3 CLINICAL TRIAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SCHOOL CHILD; SIDE EFFECT; SLEEP DISORDER; URINE RETENTION; VIRAL GASTROENTERITIS; VOMITING; WEIGHT REDUCTION; AGING; DOUBLE BLIND PROCEDURE; DRUG ANTAGONISM; ELECTROCARDIOGRAPHY; MIDDLE AGED; OXIMETRY; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE NAUSEA AND VOMITING; SAMPLE SIZE;

ADOLESCENT; ADULT; AGED; AGING; ANDROSTANOLS; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; FEMALE; GAMMA-CYCLODEXTRINS; HUMANS; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; OXIMETRY; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE NAUSEA AND VOMITING; SAMPLE SIZE; YOUNG ADULT;

EID: 61549120102     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e318194caaa     Document Type: Article

References (34)

1. Baillard C, Clec'h C, Catineau J, Salhi F, Gehan G, Cupa M, Samama CM: Postoperative residual neuromuscular block: A survey of management. Br J Anaesth 2005; 95:622-6
2. Baillard C, Gehan G, Reboul-Marty J, Larmignat P, Samama CM, Cupa M: Residual curarization in the recovery room after vecuronium. Br J Anaesth 2000; 84:394-5
3. Baxter MR, Bevan JC, Samuel J, Donati F, Bevan DR: Postoperative neuromuscular function in pediatric day-care patients. Anesth Analg 1991; 72:504-8
4. Booij LHDJ, De Boer HD, Van Egmond J: Reversal agents for nondepolarizing neuromuscular blockade: reasons for and development of a new concept. Semin Anesth Periop Med Pain 2002; 21:92-8
5. Magorian TT, Lynam DP, Caldwell JE, Miller RD: Can early administration of neostigmine, in single or repeated doses, alter the course of neuromuscular recovery from a vecuronium-induced neuromuscular blockade? A NESTHESIOLOGY 1990; 73:410-4
6. Meretoja OA, Gebert R: Postoperative neuromuscular block following atracurium or alcuronium in children. Can J Anaesth 1990; 37:743-6
7. Murphy GS, Szokol JW, Marymont JH, Franklin M, Avram MJ, Vender JS: Residual paralysis at the time of tracheal extubation. Anesth Analg 2005; 100: 1840-5
8. Adam JM, Bennett DJ, Bom A, Clark JK, Feilden H, Hutchinson EJ, Palin M, Prosser A, Rees DC, Rosair GM, Stevenson D, Tarver GJ, Zhang MQ: Cyclodextrinderived host molecules as reversal agents for the neuromuscular blocker rocuronium bromide: Synthesis and structure-activity relationships. J Med Chem 2002; 45:1806-16
9. Zhang M-Q: Drug-specific cyclodextrins: The future of rapid neuromuscular block reversal. Drugs Future 2003; 28:347-54
10. Sorgenfrei IF, Norrild K, Larsen PB, Stensballe J, Østergaard D, Prins ME, Viby-Mogensen J: Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: A dose-finding and safety study. ANESTHESIOLOGY 2006; 104:667-74
11. Suy K, Morias K, Cammu G, Hans P, van Duijnhoven WGF, Heeringa M, Demeyer I: Effective reversal of moderate rocuronium or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent. ANESTHESIOLOGY 2007; 106:283-8
12. Vanacker BF, Vermeyen KM, Struys MM, Rietbergen H, Vandermeersch E, Saldien V, Kalmar AF, Prins ME: Reversal of rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane. Anesth Analg 2007; 104:563-8
13. Shields M, Giovanelli M, Mirakhur RK, Moppett I, Adams J, Hermens Y: Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block. Br J Anaesth 2006; 96: 36-43
14. Groudine SB, Soto R, Lien C, Drover D, Roberts K: A randomized, dosefinding, phase II study of the selective relaxant binding drug, sugammadex, capable of safely reversing profound rocuronium-induced neuromuscular block. Anesth Analg 2007; 104:555-62
15. de Boer HD, Driessen JJ, Marcus MA, Kerkkamp H, Heeringa M, Klimek M: Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex. A multicenter, dose-finding and safety study. A NESTHESIOLOGY 2007; 107:239-44
16. Sparr HJ, Vermeyen KM, Beaufort AM, Rietbergen H, Proost JH, Saldien V, Velik-Salchner C, Wierda JM: Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: Efficacy, safety and pharmacokinetics. ANESTHESIOLOGY 2007; 106:935-43
17. Bom A, Bradley M, Cameron K, Clark JK, Van Egmond J, Feilden H, MacLean EJ, Muir AW, Palin R, Rees DC, Zhang MQ: A novel concept of reversing neuromuscular block: Chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angew Chem Int Ed Engl 2002; 41:266-70
18. Fisher DM: Neuromuscular blocking agents in paediatric anaesthesia. Br J Anaesth 1999; 83:58-64
19. Woelfel SK, Brandom BW, McGowan FX, Gronert BK, Cook DR: Neuromuscular effects of 600 g.kg-1 of rocuronium in infants during nitrous oxidehalothane anaesthesia. Paediatr Anaesth 1994; 4:173-7
20. Brandom BW, Fine GF: Neuromuscular blocking drugs in pediatric anesthesia. Anesthesiol Clin North America 2002; 20:45-58
21. Taivainen T, Meretoja OA, Erkola O, Rautoma P, Juvakoski M: Rocuronium in infants, children and adults during balanced anesthesia. Paediatr Anaesth 1996; 6:271-5
22. Kopman AF, Yee PS, Neuman GG: Relationship of the train-of-four fade ratio to clinical signs and symptoms of residual paralysis in awake volunteers. ANESTHESIOLOGY 1997; 86:765-71
23. Debaene B, Plaud B, Dilly M-P, Donati F: Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. ANESTHESIOLOGY 2003; 98:1042-8
24. Eriksson LI: Evidence-based practice and neuromuscular monitoring: It's time for routine quantitative assessment. ANESTHESIOLOGY 2003; 98:1037-9
25. Fuchs-Buder T, Claudius C, Skovgaard LT, Eriksson LI, Mirakhur RK, Viby-Morgensen J: 8th International Neuromuscular Meeting: Good clinical practice in pharmacodynamic studies of neuromuscular blocking agents II: The Stockholm Revision. Acta Anaesthesiol Scand 2007; 51:789-808
26. Dahaba AA, Rehak PH, List WF: Assessment of accelerography with the TOFGUARD: A comparison with electromyography. Eur J Anaesthesiol 1997; 14:623-9
27. Driessen JJ, Robertson EN, Booij LH: Acceleromyography in neonates and small infants: baseline calibration and recovery of the responses after neuromuscular blockade with rocuronium. Eur J Anaesthesiol 2005; 22:11-5
28. Eikermann M, Groeben H, Hüsing J, Peters J: Accelerometry of adductor pollicis muscle predicts recovery of respiratory function from neuromuscular blockade. ANESTHESIOLOGY 2003; 98:1333-7
29. Capron F, Alla F, Hottier C, Meistelman C, Fuchs-Buder T: Can acceleromyography detect low levels of residual paralysis? A Probability Approach to Detect a Mechanomyographic Train-of-four Ratio of 0.9. ANESTHESIOLOGY 2004; 100:1119-24
30. Kopman AF: Normalization of the acceleromyographic train-of-four fade ratio. Acta Anaesthesiol Scand 2005; 49:1575-6
31. Tobin JR, Shafer SL, Davis PJ: Pediatric research and scholarship: Another Gordian knot? Anesth Analg 2006; 103:43-8
32. Schultheis LW, Mathis LL, Roca RA, Simone AF, Hertz SH, Rappaport BA: Pediatric drug development in anesthesiology: An FDA perspective. Anesth Analg 2006; 103:49-51
33. Epemolu O, Bom A, Hope F, Mason R: Reversal of neuromuscular blockade and simultaneous increase in plasma rocuronium concentration after the intravenous infusion of the novel reversal agent Org 25969. ANESTHESIOLOGY 2003; 99:632-7
34. Gijsenbergh F, Ramael S, Houwing N, van Iersel T: First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide. ANESTHESIOLOGY 2005; 103:695-703